Myovant Sciences Ltd. Deferred Revenue (Non-Current)
Myovant Sciences Ltd. had Deferred Revenue (Non-Current) of $350.01 million as of 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2023-01-26
- 2022-12-31: Deferred Revenue, Noncurrent $350.01M.
- 2022-09-30: Deferred Revenue, Noncurrent $379.32M.
- 2022-06-30: Deferred Revenue, Noncurrent $350.56M.
- 2022-03-31: Deferred Revenue, Noncurrent $375.71M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2022-12-31 | $350.01M 10-Q · filed 2023-01-26 |
| 2022-09-30 | $379.32M 10-Q · filed 2022-10-26 |
| 2022-06-30 | $350.56M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $375.71M 10-Q · filed 2023-01-26 |
| 2021-12-31 | $400.85M 10-Q · filed 2022-01-26 |
| 2021-09-30 | $426.02M 10-Q · filed 2021-10-26 |
| 2021-06-30 | $451.19M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $397.37M 10-K · filed 2022-05-11 |
| 2020-12-31 | $418.34M 10-Q · filed 2021-02-11 |
| 2020-03-31 | $0.00 10-K · filed 2021-05-11 |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-11 |